Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by SPCEO1on Feb 11, 2021 11:10am
71 Views
Post# 32537736

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:The chat

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:The chat I have no disagreement with your assertion that Buffett does not typically invest in businesses like biotech but that was not the point. The point was that any business needs to make wise capital acquisition and allocation decisions to be optimally effective. Whether you are a coal miner or a biotech, you need to do that well or you get a sub-optimal long term result. Buffett is hyper focused on such matters and it one reason why he is the investment icon he is today. Had he ever invested in a biotech, based on his excellent track record of acquiring and deploying capital, I am pretty sure he would have never touched that particular financing.

jfm1330 wrote: No disrespect intended, but not every business are raising capital on the back of science in animals being applicable to humans with possibility of total failure. Buffet was never in highly speculative companies like that. His motto was to only invest in what he was able to understand. 

SPCEO1 wrote: No disrespect intended but you are off the mark here. Wise capital acquisition and allocation is important in every business.
jfm1330 wrote: Buffett never managed a biotech in need of cash to develop high risk clinical projects. Sorry, but the comparison is not relevant.


SPCEO1 wrote: Buffett would never have done that deal, 

 

 




<< Previous
Bullboard Posts
Next >>